Background

X10 Natural Enhancement Supplement was being sold online and in select stores with the aim of improving sexual function. Although marketed as a natural product, the Korea Food & Drug Administration identified the possibility that it contains undisclosed pharmaceutical ingredients. The agency promptly issued a warning to protect consumers, putting the credibility of the broader supplement market under scrutiny.

Regulatory Action

The Korea Food & Drug Administration recommends halting the purchase and use of the supplement. The regulator notes that if a product contains drug ingredients that are not disclosed, it may be classified as a medicinal product rather than a food. This action is interpreted as an effort to intensify enforcement against supplements that contain illegal substances.

Market Impact

The sexual‑health supplement market continues to grow, but this warning is likely to trigger increased labeling scrutiny and ingredient verification for similar products. Companies will face pressure to enhance transparency of ingredient disclosures and to substantiate claims with clinical data, which could raise product development costs. Additionally, consumer preference for validated brands is expected to strengthen.

Consumer Trust

Cases where hidden drug ingredients are discovered can severely undermine consumer confidence. Shoppers will be urged to scrutinize ingredient lists and certification marks when purchasing supplements, potentially altering purchasing patterns across the market. In the long term, stronger collaboration between regulators and manufacturers will be necessary.